$27.35
-0.40-1.44%
al cierre: -
$27.36
0.010000.04%
After hour: 5:39 PM EDT
Comments
Loading...
Estimaciones de beneficios, BPA e ingresos
Apellis Pharmaceuticals informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Fecha de beneficios
nov 4
Estimación de BPA
$-0.113
Estimación de ingresos trimestrales
$217.01M
Ingresos anuales
(a partir de jun 30)
(a partir de jun 30)
$754.65M
Analice el historial de beneficios de Apellis Pharmaceuticals utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
APLS | Apellis Pharmaceuticals | -$0.46 | -$0.11 | — | — | $196.83M | $217.01M | — | — | 11/04/2025 | |
APLS | Apellis Pharmaceuticals | -$0.30 | -$0.48 | -$0.33 | 28.26% | $199.69M | $187.79M | $178.49M | -5.27% | 07/31/2025 | |
APLS | Apellis Pharmaceuticals | -$0.54 | -$0.35 | -$0.74 | -117.65% | $172.32M | $196.49M | $166.80M | -15.59% | 05/07/2025 | |
APLS | Apellis Pharmaceuticals | -$0.73 | -$0.39 | -$0.29 | 27.50% | $146.38M | $198.35M | $212.53M | 7.39% | 02/28/2025 | |
APLS | Apellis Pharmaceuticals | -$1.17 | -$0.30 | -$0.46 | -53.33% | $110.40M | $200.35M | $196.83M | -1.76% | 11/05/2024 | |
APLS | Apellis Pharmaceuticals | -$1.02 | -$0.32 | -$0.28 | 12.50% | $94.97M | $191.51M | $199.69M | 3.05% | 08/01/2024 | |
APLS | Apellis Pharmaceuticals | -$1.56 | -$0.52 | -$0.54 | -3.85% | $44.85M | $163.35M | $172.32M | 5.49% | 05/07/2024 | |
APLS | Apellis Pharmaceuticals | -$1.50 | -$0.69 | -$0.73 | -5.80% | $22.66M | $143.59M | $146.38M | 1.94% | 02/27/2024 | |
APLS | Apellis Pharmaceuticals | -$1.75 | -$0.85 | -$1.17 | -37.65% | $22.06M | $99.74M | $110.40M | 10.69% | 11/01/2023 | |
APLS | Apellis Pharmaceuticals | -$1.46 | -$1.32 | -$1.02 | 22.73% | $16.32M | $70.25M | $94.97M | 35.19% | 07/31/2023 | |
APLS | Apellis Pharmaceuticals | -$1.42 | -$1.46 | -$1.56 | -6.85% | $14.38M | $26.10M | $44.85M | 71.82% | 05/04/2023 | |
APLS | Apellis Pharmaceuticals | -$1.61 | -$1.57 | -$1.50 | 4.46% | $60.29M | $24.19M | $22.66M | -6.31% | 02/21/2023 | |
APLS | Apellis Pharmaceuticals | -$1.57 | -$1.45 | -$1.75 | -20.69% | $5.65M | $21.59M | $22.06M | 2.16% | 11/07/2022 | |
APLS | Apellis Pharmaceuticals | -$2.72 | -$1.36 | -$1.46 | -7.35% | $623.00K | $16.94M | $16.32M | -3.65% | 08/08/2022 | |
APLS | Apellis Pharmaceuticals | -$2.32 | -$1.32 | -$1.42 | -7.58% | $0.00 | $12.57M | $14.38M | 14.41% | 05/04/2022 | |
APLS | Apellis Pharmaceuticals | $0.93 | -$1.54 | -$1.61 | -4.55% | $250.00M | $8.78M | $60.29M | 586.67% | 02/28/2022 | |
APLS | Apellis Pharmaceuticals | -$1.79 | -$1.75 | -$1.57 | 10.29% | $646.00K | $7.22M | $5.65M | -21.75% | 11/08/2021 | |
APLS | Apellis Pharmaceuticals | -$1.57 | -$1.70 | -$2.72 | -60.00% | $0.00 | $810.00K | $623.00K | -23.09% | 08/09/2021 | |
APLS | Apellis Pharmaceuticals | -$2.29 | -$1.62 | -$2.32 | -43.21% | $0.00 | $2.27M | $0.00 | -100.00% | 04/28/2021 | |
APLS | Apellis Pharmaceuticals | -$1.77 | — | $0.93 | — | $0.00 | $96.09M | $250.00M | 160.17% | 02/25/2021 | |
APLS | Apellis Pharmaceuticals | -$1.09 | — | -$1.79 | — | $0.00 | — | $646.00K | — | 11/02/2020 |
Apellis Pharmaceuticals (APLS) Ganancias por acción
Monto sorpresa de ganancias trimestrales
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-07-31 | $-0.33 | $-0.48 | 28.3 % |
| Q1 | 2025-05-07 | $-0.74 | $-0.35 | -117.7 % |
| Q4 | 2025-02-28 | $-0.29 | $-0.39 | 27.5 % |
| Q3 | 2024-11-05 | $-0.46 | $-0.30 | -53.3 % |
Apellis Pharmaceuticals (APLS) Ingresos
Monto sorpresa de ingresos trimestrales
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-07-31 | $178.49M | $187.79M | -5.27 % |
| Q1 | 2025-05-07 | $166.80M | $196.49M | -15.6 % |
| Q4 | 2025-02-28 | $212.53M | $198.35M | 7.39 % |
| Q3 | 2024-11-05 | $196.83M | $200.35M | -1.76 % |
PREGUNTAS FRECUENTES
¿Cuándo Apellis Pharmaceuticals (NASDAQ:APLS) publicará los resultados?
Está previsto que Apellis Pharmaceuticals (APLS) presente resultados el noviembre 4, 2025. Los últimos resultados se publicaron el julio 31, 2025 para el Q2.
¿Cuáles han sido los últimos beneficios por acción (BPA) de Apellis Pharmaceuticals (NASDAQ:APLS)?
El BPA real fue de $-0.33, que superó la estimación de $-0.48.
¿Cuáles fueron los ingresos de Apellis Pharmaceuticals (NASDAQ:APLS)?
Los ingresos reales fueron $178.5M, que no alcanzó la estimación de $187.8M.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.